Lupin Pharmaceuticals signs agreement with Exeltis to promote Solosec in US
Indian pharma company Lupin Pharmaceuticals has signed an agreement with Exeltis USA to promote its antimicrobial drug Solosec (secnidazole) in the US market. Solosec is ... Read More